Bionime Corporation (4737.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In TWD
| Market Cap | 4B |
| Enterprise Value | 6.64B |
| P/E Ratio | -16.11 |
| PEG Ratio | 0.25 |
| Price/Sales Ratio | 2.52 |
| Price/Book Ratio | 1.92 |
| Enterprise/Revenue | 3.75 |
| Enterprise/EBITDA | -62.73 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.14 |
| Operating Margin | -0.16 |
| Return On Assets | -0.04 |
| Return On Equity | -0.13 |
| Revenue | 1.84B |
| Revenue/Share | 24.01 |
| Gross Profit | 627.81M |
| EBITDA | -15.08M |
| Net Income | -180.28M |
| Diluted EPS | -2.65 |
| Total Cash | 449.44M |
| Total Cash/Share | 6.12 |
| Total Debt | 2.56B |
| Total Debt/Equity | 1.16 |
| Current Ratio | 0.85 |
| Book Value Per Share | 30.15 |
| 52-Week Change | -17.93 |
| 52-Week High | 73.9 |
| 52-Week Low | 49.75 |
| Moving Average 50 Days | 59.26 |
| Moving Average 200 Days | 60.02 |
| Average Volume | 147,241 |
| Shares Outstanding | 77.29M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1099:1000 |
| Last Split Date | September 08, 2025 |